Private Advisor Group, LLC Karyopharm Therapeutics Inc. Transaction History

Private Advisor Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$8.11 - $11.11 $89,777 - $122,987	-11,070 Closed	0 $0
Q1 2021 Apr 22, 2021	BUY	$9.85 - $17.69 $1,310 - $2,352	133 Added 1.22%	11,070 $116,000
Q4 2020 Apr 01, 2021	BUY	$14.15 - $17.19 $154,758 - $188,007	10,937 New	10,937 $169,000
Q3 2020 Nov 02, 2020	SELL	$14.14 - $19.71 $4,949 - $6,898	-350 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$16.6 - $25.25 $5,810 - $8,837	350 New	350 $7,000

120

72.4M

476K

175K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $69.4M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.